Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 3:54 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 145–168 of 331 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Observational data collection Clear all

Conditions: Severe Eosinophilic Asthma, Nasal Polyps
Interventions: FASENRA(benralizumab); Other
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 273 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 8
States / cities: Centennial, Colorado • Denver, Colorado • Glendale, New York + 5 more

Conditions: Non Small Cell Lung Cancer
Interventions: Observational; Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Noise Exposure, Sedative Withdrawal Delirium, Sedative Toxicity
Interventions: Decibel Monitor; Other
Lead sponsor: Children's National Research Institute; Other
Eligibility: Up to 22 Years
Enrollment: 64 participants
Timeline: 2021
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Malignant Solid Neoplasm, Hematopoietic Neoplasms, Lymphatic System Neoplasm
Interventions: Surveys/Questionnaires; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 15 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Interventions: Survey Administration, Interview, Educational Intervention, Assessment, Internet-Based Intervention, Electronic Health Record Review; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 216 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 39
States / cities: Tuscaloosa, Alabama • Fort Smith, Arkansas • Jonesboro, Arkansas + 30 more

Conditions: COVID, Corona Virus Infection, COVID19
Interventions: Human cord tissue mesenchymal stromal cells (hCT-MSC) manufactured by Duke University., Placebo; Biological · Other
Lead sponsor: Joanne Kurtzberg, MD; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 5
States / cities: Boca Raton, Florida • Miami, Florida • Valhalla, New York + 1 more

Conditions: Childhood Cancer
Interventions: Data Collection; Other
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Not listed
Enrollment: 30,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2045
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: GastroEsophageal Cancer
Interventions: Dietitian Consultation, Survey, Fitbit Data Collection, Referral to Dietitian, Social Determinants of Health Survey (SDOH); Behavioral
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Tampa, Florida • Chapel Hill, North Carolina

Conditions: Metastatic Malignant Neoplasm in the Spine
Interventions: Electronic Health Record Review; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: Not listed
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Stillbirth, Placental Insufficiency
Interventions: Data Collection Throughout Pregnancy and Delivery; Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 15 Years to 50 Years · Female only
Enrollment: 640 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Advanced Cancer
Interventions: Observation of provider-patient interactions and interviews; Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 473 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Outpatient Parenteral Antibiotic Therapy
Interventions: OPAT, Focus Group; Other
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 100 Years
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Lung Cancer Screening
Interventions: Sybil Artificial Intelligence (AI) screening; Diagnostic Test
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 50 Years to 80 Years
Enrollment: 2,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2038
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Sarcoma
Interventions: Not listed
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: Not listed
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Mild Cognitive Impairment, Subjective Cognitive Decline
Interventions: Assessments, Neuroimaging volumetric measures, Biofluid samples; Behavioral · Other
Lead sponsor: Ohio State University; Other
Eligibility: 50 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2032
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Breast Carcinoma, Cholangiocarcinoma, Colorectal Carcinoma, Gastric Carcinoma, Malignant Digestive System Neoplasm, Pancreatic Carcinoma, Prostate Carcinoma
Interventions: Interview, Survey Administration; Other
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Carbon Monoxide Poisoning
Interventions: Observational data collection; Device
Lead sponsor: Nonin Medical, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Malignant Solid Tumor, Hematologic Malignancies
Interventions: Biometric Devices, Physical Performance Testing; Device · Other
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Osteoarthritis
Interventions: Noni Juice; Dietary Supplement
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 40 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Rockford, Illinois

Conditions: Breast Cancer
Interventions: Breast Ultrasound Imaging With Investigational AI Software; Device
Lead sponsor: AURA Health Technologies; Industry
Eligibility: 21 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Autism, Autism Spectrum Disorder, Autism Spectrum Disorder (ASD), Neurodevelopmental Conditions
Interventions: BlinkLab Dx1, Retrospective Neurodevelopmental Diagnostic Assessment; Diagnostic Test · Behavioral
Lead sponsor: Blinklab Limited; Industry
Eligibility: 2 Years to 11 Years
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Princeton, New Jersey

Conditions: RSV Infections
Interventions: Not listed
Lead sponsor: Shionogi; Industry
Eligibility: Up to 36 Months
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Syracuse, New York • Seattle, Washington

Conditions: Neoplasms
Interventions: TSR-033, Dostarlimab, mFOLFOX6, FOLFIRI, Bevacizumab; Drug
Lead sponsor: Tesaro, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 111 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 11
States / cities: Los Angeles, California • Whittier, California • Sarasota, Florida + 8 more

Conditions: Prostate Cancer
Interventions: Active surveillance; Other
Lead sponsor: Jonsson Comprehensive Cancer Center; Other
Eligibility: 30 Years to 85 Years · Male only
Enrollment: 462 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Search by objective public record fields.

RANS. Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps.

Circulating Tumor DNA Alterations in Non-small Cell Lung Cancer Patients Treated With Pembrolizumab

Sound Levels in the Pediatric Cardiac Critical Care Unit and Their Correlation With Sedation Administration, Delirium Scores and Patient Heart Rate

Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology

Understanding Needs of Older Patients Prior to Starting Cancer Treatment

hCT-MSCs for COVID19 ARDS

Protocol For Collecting Data On Patients With Childhood Cancer

Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer

Medical Data Collection for the Evaluation of Radiofrequency Ablation and Cement Augmentation for the Treatment of Secondary Metastases to the Spine

Placental Risk Assessment to CusTomize Individualized Pregnancy Care and Evaluation

Variation in Cancer Centers' End-of-Life Quality

Mobile-health Approach to Gather Clinical Information From Patients Following Hospital Discharge

LUNG-07: Advancing Precision-Based Lung Cancer Screening: Implementation, AI-Guided Risk Stratification, and Biomarker Integration (CREST AI)

A Study Involving Collection of Samples and Data From Sarcoma Patients Receiving Immunotherapy

Under-Represented Communities Diagnosed With SCD or MCI Through Tele-Cog

Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer

Suspected Cases of Carbon Monoxide Poisoning in the ED

Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data Generation

A Pilot Observational Clinical Survey: Impacts of Tahitian Noni Juice on the Quality of Life of Patients With Osteoarthritis

Prospective Ultrasound Data Collection Study for AI-Based Detection of Breast Biopsy Markers

Online Evaluation of the Diagnostic Accuracy of BlinkLab's Digital Assessments for Autism

A Study to Investigate How Respiratory Syncytial Virus (RSV) Infection Develops and Changes Over Time in Pediatric Participants

Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors

Active Surveillance for Cancer of the Prostate (ASCaP)